3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Enrolling by invitation
1
Sponsor Class
OTHER
3
INDUSTRY
2
OTHER_GOV
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Breast
1
Conditions
Breast Neoplasms
55
Carcinoma, Non-Small-Cell Lung
33
Stomach Neoplasms
28
Colorectal Neoplasms
26
Small Cell Lung Carcinoma
19
Lung Neoplasms
18
Rectal Neoplasms
16
Pancreatic Neoplasms
14
Neoplasms
14
Neoplasm Metastasis
14
Uterine Cervical Neoplasms
12
Esophageal Neoplasms
12
Ovarian Neoplasms
11
Nasopharyngeal Carcinoma
11
Carcinoma, Hepatocellular
11
Recurrence
10
Leukemia, Myeloid, Acute
10
Melanoma
9
Esophageal Squamous Cell Carcinoma
8
Colonic Neoplasms
8
Triple Negative Breast Neoplasms
7
Lymphoma, Non-Hodgkin
7
Head and Neck Neoplasms
7
Hodgkin Disease
6
Cholangiocarcinoma
6
Adenocarcinoma of Lung
6
Squamous Cell Carcinoma of Head and Neck
5
Prostatic Neoplasms
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Neoplasms, Germ Cell and Embryonal
5
Interventions
Alginates
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
OTHER_GOV
×
Esophagitis
×
Clear all
NCT06958445
2025-05-06
SAFE
Taipei City Hospital
Phase 2
Enrolling by invitation
90 enrolled